138 related articles for article (PubMed ID: 11448945)
21. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
[TBL] [Abstract][Full Text] [Related]
22. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
23. Chromatin-dependent regulation of the MMTV promoter by cAMP signaling is mediated through distinct pathways.
Mulholland NM; Snyder SK; Kolla SS; Smith CL
Exp Cell Res; 2003 Jul; 287(2):361-73. PubMed ID: 12837291
[TBL] [Abstract][Full Text] [Related]
24. DNA sequences outside the receptor-binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones.
Cato AC; Skroch P; Weinmann J; Butkeraitis P; Ponta H
EMBO J; 1988 May; 7(5):1403-10. PubMed ID: 2842149
[TBL] [Abstract][Full Text] [Related]
25. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
26. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
Boronat S; Richard-Foy H; Piña B
J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
[TBL] [Abstract][Full Text] [Related]
27. Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.
Mymryk JS; Berard D; Hager GL; Archer TK
Mol Cell Biol; 1995 Jan; 15(1):26-34. PubMed ID: 7799933
[TBL] [Abstract][Full Text] [Related]
28. Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter.
Ma H; Baumann CT; Li H; Strahl BD; Rice R; Jelinek MA; Aswad DW; Allis CD; Hager GL; Stallcup MR
Curr Biol; 2001 Dec; 11(24):1981-5. PubMed ID: 11747826
[TBL] [Abstract][Full Text] [Related]
29. Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters.
Georgel PT; Fletcher TM; Hager GL; Hansen JC
Genes Dev; 2003 Jul; 17(13):1617-29. PubMed ID: 12842912
[TBL] [Abstract][Full Text] [Related]
30. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
[TBL] [Abstract][Full Text] [Related]
31. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.
Cato AC; Henderson D; Ponta H
EMBO J; 1987 Feb; 6(2):363-8. PubMed ID: 3034586
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: II. Receptor-antiglucocorticoid complexes do not interact productively with mouse mammary tumor virus long terminal repeat chromatin.
Richard-Foy H; Sistare FD; Riegel AT; Simons SS; Hager GL
Mol Endocrinol; 1987 Sep; 1(9):659-65. PubMed ID: 2856414
[TBL] [Abstract][Full Text] [Related]
33. Histone hyperacetylation does not alter the positioning or stability of phased nucleosomes on the mouse mammary tumor virus long terminal repeat.
Bresnick EH; John S; Hager GL
Biochemistry; 1991 Apr; 30(14):3490-7. PubMed ID: 1849427
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter.
Archer TK; Cordingley MG; Wolford RG; Hager GL
Mol Cell Biol; 1991 Feb; 11(2):688-98. PubMed ID: 1846670
[TBL] [Abstract][Full Text] [Related]
35. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter.
Astrand C; Belikov S; Wrange O
Exp Cell Res; 2009 Sep; 315(15):2604-15. PubMed ID: 19463811
[TBL] [Abstract][Full Text] [Related]
36. Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.
Vicent GP; Zaurin R; Nacht AS; Font-Mateu J; Le Dily F; Beato M
J Biol Chem; 2010 Jan; 285(4):2622-31. PubMed ID: 19940123
[TBL] [Abstract][Full Text] [Related]
37. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo.
Wilson MA; Ricci AR; Deroo BJ; Archer TK
J Biol Chem; 2002 Apr; 277(17):15171-81. PubMed ID: 11821430
[TBL] [Abstract][Full Text] [Related]
38. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells.
Medh RD; Schmidt TJ
J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):129-42. PubMed ID: 9393948
[TBL] [Abstract][Full Text] [Related]
39. Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway.
Pennie WD; Hager GL; Smith CL
Mol Cell Biol; 1995 Apr; 15(4):2125-34. PubMed ID: 7891707
[TBL] [Abstract][Full Text] [Related]
40. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
